Nanotechnology and glaucoma: A review of the potential implications of glaucoma nanomedicine

Nathaniel J. Kim, Alon Harris, Austin Gerber, Leslie Abrams Tobe, Annahita Amireskandari, Andrew Huck, Brent Siesky

Research output: Contribution to journalReview article

19 Citations (Scopus)

Abstract

The purpose of this review is to discuss the evolution of nanotechnology and its potential diagnostic and therapeutic applications in the field of ophthalmology, particularly as it pertains to glaucoma. We reviewed literature using MEDLINE and PubMed databases with the following search terms: glaucoma, nanotechnology, nanomedicine, nanoparticles, ophthalmology and liposomes. We also reviewed pertinent references from articles found in this search. A brief history of nanotechnology and nanomedicine will be covered, followed by a discussion of the advantages and concerns of using this technology in the field of glaucoma. We will look at various studies concerning the development of nanomedicine, its potential applications in ocular drug delivery, diagnostic and imaging modalities and, surgical techniques. In particular, the challenges of assuring safety and efficacy of nanomedicine will be examined. We conclude that nanotechnology offers a novel approach to expanding diagnostic, imaging and surgical modalities in glaucoma and may contribute to the knowledge of disease pathogenesis at a molecular level. However, more research is needed to better elucidate the mechanism of cellular entry, the potential for nanoparticle cytotoxicity and the assurance of clinical efficacy.

Original languageEnglish (US)
Pages (from-to)427-431
Number of pages5
JournalBritish Journal of Ophthalmology
Volume98
Issue number4
DOIs
StatePublished - Apr 2014

Fingerprint

Nanomedicine
Nanotechnology
Glaucoma
Ophthalmology
Diagnostic Imaging
Nanoparticles
PubMed
MEDLINE
Liposomes
Databases
Technology
Safety
Research
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Nanotechnology and glaucoma : A review of the potential implications of glaucoma nanomedicine. / Kim, Nathaniel J.; Harris, Alon; Gerber, Austin; Tobe, Leslie Abrams; Amireskandari, Annahita; Huck, Andrew; Siesky, Brent.

In: British Journal of Ophthalmology, Vol. 98, No. 4, 04.2014, p. 427-431.

Research output: Contribution to journalReview article

Kim, Nathaniel J. ; Harris, Alon ; Gerber, Austin ; Tobe, Leslie Abrams ; Amireskandari, Annahita ; Huck, Andrew ; Siesky, Brent. / Nanotechnology and glaucoma : A review of the potential implications of glaucoma nanomedicine. In: British Journal of Ophthalmology. 2014 ; Vol. 98, No. 4. pp. 427-431.
@article{128fe8852e2d4257a9a1227aa37a2f60,
title = "Nanotechnology and glaucoma: A review of the potential implications of glaucoma nanomedicine",
abstract = "The purpose of this review is to discuss the evolution of nanotechnology and its potential diagnostic and therapeutic applications in the field of ophthalmology, particularly as it pertains to glaucoma. We reviewed literature using MEDLINE and PubMed databases with the following search terms: glaucoma, nanotechnology, nanomedicine, nanoparticles, ophthalmology and liposomes. We also reviewed pertinent references from articles found in this search. A brief history of nanotechnology and nanomedicine will be covered, followed by a discussion of the advantages and concerns of using this technology in the field of glaucoma. We will look at various studies concerning the development of nanomedicine, its potential applications in ocular drug delivery, diagnostic and imaging modalities and, surgical techniques. In particular, the challenges of assuring safety and efficacy of nanomedicine will be examined. We conclude that nanotechnology offers a novel approach to expanding diagnostic, imaging and surgical modalities in glaucoma and may contribute to the knowledge of disease pathogenesis at a molecular level. However, more research is needed to better elucidate the mechanism of cellular entry, the potential for nanoparticle cytotoxicity and the assurance of clinical efficacy.",
author = "Kim, {Nathaniel J.} and Alon Harris and Austin Gerber and Tobe, {Leslie Abrams} and Annahita Amireskandari and Andrew Huck and Brent Siesky",
year = "2014",
month = "4",
doi = "10.1136/bjophthalmol-2013-304028",
language = "English (US)",
volume = "98",
pages = "427--431",
journal = "British Journal of Ophthalmology",
issn = "0007-1161",
publisher = "BMJ Publishing Group",
number = "4",

}

TY - JOUR

T1 - Nanotechnology and glaucoma

T2 - A review of the potential implications of glaucoma nanomedicine

AU - Kim, Nathaniel J.

AU - Harris, Alon

AU - Gerber, Austin

AU - Tobe, Leslie Abrams

AU - Amireskandari, Annahita

AU - Huck, Andrew

AU - Siesky, Brent

PY - 2014/4

Y1 - 2014/4

N2 - The purpose of this review is to discuss the evolution of nanotechnology and its potential diagnostic and therapeutic applications in the field of ophthalmology, particularly as it pertains to glaucoma. We reviewed literature using MEDLINE and PubMed databases with the following search terms: glaucoma, nanotechnology, nanomedicine, nanoparticles, ophthalmology and liposomes. We also reviewed pertinent references from articles found in this search. A brief history of nanotechnology and nanomedicine will be covered, followed by a discussion of the advantages and concerns of using this technology in the field of glaucoma. We will look at various studies concerning the development of nanomedicine, its potential applications in ocular drug delivery, diagnostic and imaging modalities and, surgical techniques. In particular, the challenges of assuring safety and efficacy of nanomedicine will be examined. We conclude that nanotechnology offers a novel approach to expanding diagnostic, imaging and surgical modalities in glaucoma and may contribute to the knowledge of disease pathogenesis at a molecular level. However, more research is needed to better elucidate the mechanism of cellular entry, the potential for nanoparticle cytotoxicity and the assurance of clinical efficacy.

AB - The purpose of this review is to discuss the evolution of nanotechnology and its potential diagnostic and therapeutic applications in the field of ophthalmology, particularly as it pertains to glaucoma. We reviewed literature using MEDLINE and PubMed databases with the following search terms: glaucoma, nanotechnology, nanomedicine, nanoparticles, ophthalmology and liposomes. We also reviewed pertinent references from articles found in this search. A brief history of nanotechnology and nanomedicine will be covered, followed by a discussion of the advantages and concerns of using this technology in the field of glaucoma. We will look at various studies concerning the development of nanomedicine, its potential applications in ocular drug delivery, diagnostic and imaging modalities and, surgical techniques. In particular, the challenges of assuring safety and efficacy of nanomedicine will be examined. We conclude that nanotechnology offers a novel approach to expanding diagnostic, imaging and surgical modalities in glaucoma and may contribute to the knowledge of disease pathogenesis at a molecular level. However, more research is needed to better elucidate the mechanism of cellular entry, the potential for nanoparticle cytotoxicity and the assurance of clinical efficacy.

UR - http://www.scopus.com/inward/record.url?scp=84896542786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896542786&partnerID=8YFLogxK

U2 - 10.1136/bjophthalmol-2013-304028

DO - 10.1136/bjophthalmol-2013-304028

M3 - Review article

C2 - 24246373

AN - SCOPUS:84896542786

VL - 98

SP - 427

EP - 431

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

IS - 4

ER -